Eyebright Medical Technology (Beijing) (688050.SS) Earnings Analysis
Eyebright Medical Technology (Beijing) (688050.SS) next reports earnings on 2026-08-26, consensus EPS 0.613 CNY. Last quarter (2026-04-22) it missed with EPS 0.4658 CNY vs 0.53 CNY est (-12.1%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E 29.93.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688050.SS next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | 0.613 CNY |
| Revenue estimate | 0.49B |
688050.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.4658 CNY | 0.53 CNY | -12.1% | Miss |
| 2026-02-27 | -0.11369 CNY | 0.2399 CNY | -147.4% | Miss |
| 2025-10-30 | 0.3979 CNY | 0.641 CNY | -37.9% | Miss |
| 2025-02-06 | 0.36 CNY | 0.29 CNY | +24.1% | Beat |
| 2024-08-21 | 0.56 CNY | 0.46 CNY | +21.7% | Beat |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
688050.SS valuation and analyst view
| Trailing P/E | 29.93 |
|---|---|
| Trailing EPS | 1.351 CNY |
| Price / book | 2.74 |
| Dividend yield | 0.79% |
| Market cap | 7.93B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Eyebright Medical Technology (Beijing) (688050.SS)'s next earnings date?
Eyebright Medical Technology (Beijing) is next scheduled to report on 2026-08-26, with a consensus EPS estimate of 0.613 CNY and revenue estimate of 0.49B.
Did 688050.SS beat earnings last quarter?
In its 2026-04-22 report, 688050.SS posted EPS of 0.4658 CNY versus a 0.53 CNY estimate — a miss of 12.1%.
What is 688050.SS's earnings track record?
Over the last 5 reported quarters with consensus data, 688050.SS beat estimates 2 times (40%).
What is 688050.SS's current P/E ratio and EPS?
688050.SS trades at a trailing P/E of 29.93 on trailing EPS of 1.3506463694184394 CNY.
What do analysts rate 688050.SS?
688050.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.